Skip to main content

Table 1 Susceptibility testing of Mycobacterium mucogenicum isolate

From: Mycobacterium mucogenicum bacteremia: major role of clinical microbiologists

Antimicrobial drugs Minimal inhibitory concentration (mg/L) Clinical breakpoints* (mg/L)
amikacin 2 16–64
tobramycin 8 2–8
ciprofloxacin 0.5 1–4
moxifloxacin < 0.25 1–4
clarithromycin 0.5 2–8
linezolid 2 4–32
trimetoprim/sulfamethoxazole < 0.25/4.75 2/38–4/76
cefoxitin < 4 16–128
imipenem < 2 4–32
doxycyclin 0.25 1–8
minocyclin < 1 1–8
  1. *Clinical breakpoints according to the European Committee on Antimicrobial Susceptibility Testing (EUCAST)